Molybdenum Cofactor Deficiency
&nbsp;
Molybdenum cofactor deficiency (MoCoD-A) is a severe autosomal recessive inborn error of metabolism characterized by the neonatal presentation of intractable seizures, feeding difficulties, developmental delays, microcephaly with brain atrophy, and coarse facial features.
It is caused by homozygous or compounds heterozygous mutation in the MOCS1 gene on chromosome 6p21dueto, in which patients cannot produce a substance known as cyclic pyranopterin monophosphate (cGMP). This results in deficiency of the molybdenum cofactor-dependent enzymes sulfite oxidase, xanthine dehydrogenase, aldehyde oxidase, and mitochondrial amidoxime reducing component.
&nbsp;
Molybdenum Cofactor Deficiency Epidemiology Segmentation in the 7MM
&nbsp;
<ul>
<li class="ql-align-justify">Total Prevalent cases of MoCoD</li>
<li>&nbsp;</li>
<li class="ql-align-justify">Total Diagnosed Prevalent Population of MoCoD</li>
<li>&nbsp;</li>
<li class="ql-align-justify">Total Type-specific Diagnosed Prevalent cases of MoCoD</li>
</ul>
&nbsp;
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/molybdenum-cofactor-deficiency-type-a-mocod-a-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Molybdenum Cofactor Deficiency Epidemiological Insights</a> Observed in the 7MM
(2021)
&nbsp;
<ul>
<li class="ql-align-justify">The total prevalent cases of Molybdenum cofactor deficiency in 7MM were found to be 242 cases.</li>
<li class="ql-align-justify">The total prevalent cases of Molybdenum cofactor deficiency were highest in the US, accounting for approximately 124 cases.&nbsp;</li>
<li class="ql-align-justify">The total prevalent cases of Molybdenum cofactor deficiency were second highest in EU5, comprising more than 92 cases.</li>
<li class="ql-align-justify">The total prevalent cases of Molybdenum cofactor deficiency in Japan were found to be 26 cases.&nbsp;</li>
</ul>
&nbsp;
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/molybdenum-cofactor-deficiency-type-a-mocod-a-market" target="_blank" rel="noopener noreferrer">Molybdenum Cofactor Deficiency Market Insight</a>
&nbsp;
<ul>
<li class="ql-align-justify">The market size of molybdenum cofactor deficiency in 7MM was approximately USD 2.42 million in 2021.&nbsp;</li>
<li class="ql-align-justify">The market size of molybdenum cofactor deficiency in the US was almost USD 2.41 million. Whereas the market size of molybdenum cofactor deficiency in EU5 was found to be approximately USD 0.01 million.&nbsp;</li>
<li class="ql-align-justify">Amongst 7MM, the market size of molybdenum cofactor deficiency in Japan was the least, accounting for approximately USD 0.003 million.&nbsp;</li>
<li class="ql-align-justify">&nbsp;</li>
</ul>
Molybdenum Cofactor Deficiency Market Strengths
&nbsp;
Increased market focus after the first US FDA approval for MoCoD type A would pique the key companies' interest and raise their awareness, encouraging research and development for MoCoD to go in new directions.
&nbsp;
&nbsp;
Molybdenum Cofactor Deficiency Market Opportunities
&nbsp;
The increasing diagnosed incidence of MoCoD, and the research and development of novel therapy alternatives are largely responsible for the market's rise. Furthermore, the rising awareness of MoCoD is likely to drive market growth throughout the forecast period.
&nbsp;
&nbsp;
Molybdenum Cofactor Deficiency Emerging Drugs
&nbsp;
The emerging drugs in the Molybdenum Cofactor Deficiency market are
<ul>
<li class="ql-align-justify">cPMP, and others</li>
</ul>
&nbsp;
Molybdenum Cofactor Deficiency Key Players&nbsp;
&nbsp;
The key players working in the Molybdenum Cofactor Deficiency market are
&nbsp;
<ul>
<li class="ql-align-justify">BridgeBio Pharma, and others</li>
</ul>
&nbsp;

Molybdenum cofactor deficiency (MOCOD)

Molybdenum cofactor deficiency (MOCOD) - Type A Market Infographic 

 Molybdenum cofactor deficiency (MOCOD) - Type A Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape